LIN vs VCEL · P/E 34, rev $33.99B vs P/E 835, rev $237.2M
Linde plc Ordinary Shares (LIN) versus Vericel Corp Ord (VCEL) — a side-by-side from cached financials, not a winner call.
Linde plc Ordinary Shares (LIN) is a specialty chemicals company listed on US.
Vericel Corp Ord (VCEL) is a biotechnology company listed on US.
Latest reported LIN revenue for 2025-12-31 was $33.99B. Net income was $6.90B. Revenue was up 3.0% from 2024-12-31 to 2025-12-31. LIN currently screens at market cap $223.87B and trailing P/E 34.5.
Latest reported VCEL revenue for 2024-12-31 was $237.2M. Net income was $10.4M. Revenue was up 20.1% from 2023-12-31 to 2024-12-31. VCEL currently screens at market cap $2.10B and trailing P/E 834.8.
LIN currently screens at market cap $223.87B and trailing P/E 34.5. VCEL currently screens at market cap $2.10B and trailing P/E 834.8.
Not investment advice. Open the LIN and VCEL stock pages for the full models.
Not investment advice.